The Cold Spring Harbor Laboratory Cancer Center is led by Dr. Bruce Stillman, Dr. Scott Lowe and Dr. Nicholas Tonks. Dr, Stillman has been the Director of the CSHL Cancer Center since 1992. As Director of the Cancer Center, he is responsible for overall direction, strategic planning and raising funds to support the research and Shared Resources. He is assisted in oversight of the Cancer Center by two Deputy Directors, Dr. Scott Lowe and Dr. Nicholas Tonks. Dr. Lowe was appointed Deputy Director for Research of the Cancer Center in 2001. In this position, he is primarily responsible for oversight of the cancer research and programs, strategic planning and recruitment of new members to the Cancer Center. Dr. Nicholas Tonks was appointed Deputy Director for Shared Resources for the Cancer Center in 2007. He supervises all the Shared Resource leaders, provides leadership on funding and is responsible for ongoing periodic Shared Resource review. These three senior leaders are committed to maintaining and improving CSHL as a premier center for cancer research.
The Director and Deputy Directors of the Cold Spring Harbor Laboratory Cancer Center oversee a dynamic and vibrant cancer research program and provide leadership for 32 scientists in three research programs who are committed to understanding the underlying mechanisms of cancer as a means to developing strategies for therapeutic intervention.
| Kumar, Vijay; Rosenbaum, Julie; Wang, Zihua et al. (2018) Partial bisulfite conversion for unique template sequencing. Nucleic Acids Res 46:e10 |
| Lee, Je H (2018) Tracing single-cell histories. Science 359:521-522 |
| Alexander, Joan; Kendall, Jude; McIndoo, Jean et al. (2018) Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate Cancer. Cancer Res 78:348-358 |
| Huang, Yu-Han; Klingbeil, Olaf; He, Xue-Yan et al. (2018) POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915-928 |
| Tiriac, Hervé; Belleau, Pascal; Engle, Dannielle D et al. (2018) Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 8:1112-1129 |
| Naguib, Adam; Mathew, Grinu; Reczek, Colleen R et al. (2018) Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells. Cell Rep 23:58-67 |
| Forcier, Talitha L; Ayaz, Andalus; Gill, Manraj S et al. (2018) Measuring cis-regulatory energetics in living cells using allelic manifolds. Elife 7: |
| Bhagwat, Anand S; Lu, Bin; Vakoc, Christopher R (2018) Enhancer dysfunction in leukemia. Blood 131:1795-1804 |
| Aberle, M R; Burkhart, R A; Tiriac, H et al. (2018) Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br J Surg 105:e48-e60 |
| Chen, Wei-Chia; Tareen, Ammar; Kinney, Justin B (2018) Density Estimation on Small Data Sets. Phys Rev Lett 121:160605 |
Showing the most recent 10 out of 380 publications
